BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 36114029)

  • 21. Overexpression of GPNMB predicts an unfavorable outcome of epithelial ovarian cancer.
    Ma RQ; Tang ZJ; Ye X; Cheng HY; Sun KK; Chang XH; Cui H
    Arch Gynecol Obstet; 2018 May; 297(5):1235-1244. PubMed ID: 29428978
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CAMK2N1/RUNX3 methylation is an independent prognostic biomarker for progression-free and overall survival of platinum-sensitive epithelial ovarian cancer patients.
    Heinze K; Rengsberger M; Gajda M; Jansen L; Osmers L; Oliveira-Ferrer L; Schmalfeldt B; Dürst M; Häfner N; Runnebaum IB
    Clin Epigenetics; 2021 Jan; 13(1):15. PubMed ID: 33482905
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NPPB is a novel candidate biomarker expressed by cancer-associated fibroblasts in epithelial ovarian cancer.
    Lawrenson K; Grun B; Lee N; Mhawech-Fauceglia P; Kan J; Swenson S; Lin YG; Pejovic T; Millstein J; Gayther SA
    Int J Cancer; 2015 Mar; 136(6):1390-401. PubMed ID: 25047817
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circular RNA profiling reveals circEXOC6B and circN4BP2L2 as novel prognostic biomarkers in epithelial ovarian cancer.
    Ning L; Long B; Zhang W; Yu M; Wang S; Cao D; Yang J; Shen K; Huang Y; Lang J
    Int J Oncol; 2018 Dec; 53(6):2637-2646. PubMed ID: 30272264
    [TBL] [Abstract][Full Text] [Related]  

  • 25. UGDH promotes tumor-initiating cells and a fibroinflammatory tumor microenvironment in ovarian cancer.
    Harrington BS; Kamdar R; Ning F; Korrapati S; Caminear MW; Hernandez LF; Butcher D; Edmondson EF; Traficante N; Hendley J; ; Gough M; Rogers R; Lourie R; Shetty J; Tran B; Elloumi F; Abdelmaksoud A; Nag ML; Mazan-Mamczarz K; House CD; Hooper JD; Annunziata CM
    J Exp Clin Cancer Res; 2023 Oct; 42(1):270. PubMed ID: 37858159
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The PDGF Family Is Associated with Activated Tumor Stroma and Poor Prognosis in Ovarian Cancer.
    Li J; Zhi X; Sun Y; Chen M; Yao L
    Dis Markers; 2022; 2022():5940049. PubMed ID: 36199822
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MARCKS contributes to stromal cancer-associated fibroblast activation and facilitates ovarian cancer metastasis.
    Yang Z; Xu S; Jin P; Yang X; Li X; Wan D; Zhang T; Long S; Wei X; Chen G; Meng L; Liu D; Fang Y; Chen P; Ma D; Gao Q
    Oncotarget; 2016 Jun; 7(25):37649-37663. PubMed ID: 27081703
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Single-Cell Sequencing of Malignant Ascites Reveals Transcriptomic Remodeling of the Tumor Microenvironment during the Progression of Epithelial Ovarian Cancer.
    Li Y; Wang W; Wang D; Zhang L; Wang X; He J; Cao L; Li K; Xie H
    Genes (Basel); 2022 Dec; 13(12):. PubMed ID: 36553542
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor-associated macrophages and the tumor immune microenvironment of primary and recurrent epithelial ovarian cancer.
    Ojalvo LS; Thompson ED; Wang TL; Meeker AK; Shih IM; Fader AN; Cimino-Mathews A; Emens LA
    Hum Pathol; 2018 Apr; 74():135-147. PubMed ID: 29288043
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Macrophages derived exosomes deliver miR-223 to epithelial ovarian cancer cells to elicit a chemoresistant phenotype.
    Zhu X; Shen H; Yin X; Yang M; Wei H; Chen Q; Feng F; Liu Y; Xu W; Li Y
    J Exp Clin Cancer Res; 2019 Feb; 38(1):81. PubMed ID: 30770776
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cancer-associated fibroblasts promote an immunosuppressive microenvironment through the induction and accumulation of protumoral macrophages.
    Takahashi H; Sakakura K; Kudo T; Toyoda M; Kaira K; Oyama T; Chikamatsu K
    Oncotarget; 2017 Jan; 8(5):8633-8647. PubMed ID: 28052009
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neoadjuvant chemotherapy (NACT) increases immune infiltration and programmed death-ligand 1 (PD-L1) expression in epithelial ovarian cancer (EOC).
    Mesnage SJL; Auguste A; Genestie C; Dunant A; Pain E; Drusch F; Gouy S; Morice P; Bentivegna E; Lhomme C; Pautier P; Michels J; Le Formal A; Cheaib B; Adam J; Leary AF
    Ann Oncol; 2017 Mar; 28(3):651-657. PubMed ID: 27864219
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High ATP6V1B1 expression is associated with poor prognosis and platinum‑based chemotherapy resistance in epithelial ovarian cancer.
    Han GH; Yun H; Chung JY; Kim JH; Cho H
    Oncol Rep; 2023 May; 49(5):. PubMed ID: 36999629
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic significance of PD-1 and PD-L1 positive tumor-infiltrating immune cells in ovarian carcinoma.
    Buderath P; Mairinger F; Mairinger E; Böhm K; Mach P; Schmid KW; Kimmig R; Kasimir-Bauer S; Bankfalvi A; Westerwick D; Hager T
    Int J Gynecol Cancer; 2019 Nov; 29(9):1389-1395. PubMed ID: 31492714
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic Significance of Increased Expression of Annexin A10 (ANXA10) in Serous Epithelial Ovarian Cancer.
    Wang J; Zhao S; Wang F; Wang J; Zhang Y
    Med Sci Monit; 2019 Jul; 25():5666-5673. PubMed ID: 31363077
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased co-expression of MEST and BRCA1 is associated with worse prognosis and immune infiltration in ovarian cancer.
    Zhang J; Yu S; Li Q; Wang Q; Zhang J
    Gynecol Oncol; 2022 Mar; 164(3):566-576. PubMed ID: 35042621
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long noncoding RNA TC0101441 induces epithelial-mesenchymal transition in epithelial ovarian cancer metastasis by downregulating KiSS1.
    Qiu JJ; Lin XJ; Tang XY; Zheng TT; Zhang XY; Hua KQ
    Int J Cancer; 2020 May; 146(9):2588-2598. PubMed ID: 31577838
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased expression of MMP17 predicts poor clinical outcomes in epithelial ovarian cancer patients.
    Xiao C; Wang Y; Cheng Q; Fan Y
    Medicine (Baltimore); 2022 Aug; 101(34):e30279. PubMed ID: 36042626
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Upregulation of centrosomal protein 55 is associated with unfavorable prognosis and tumor invasion in epithelial ovarian carcinoma.
    Zhang W; Niu C; He W; Hou T; Sun X; Xu L; Zhang Y
    Tumour Biol; 2016 May; 37(5):6239-54. PubMed ID: 26615423
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High Expression of RING Finger Protein 126 Predicts Unfavorable Prognosis of Epithelial Ovarian Cancer.
    Wang C; Wen A; Qiao J; Liu Y; Guo Y; Wang W
    Med Sci Monit; 2020 Apr; 26():e921370. PubMed ID: 32254065
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.